Sign in

Charalampos (Harris) Lazaris, Ph.D.

@chlazaris.bsky.social
39 followers 182 following 8 posts

Senior Data Scientist, Oncology Data Science at Novartis. Interested in gene regulation and deregulation in cancer. Drugging transcription. Views are my own.

PostsRepliesMedia
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 30/09/2026
🧬 Our joint meeting Precision Genome Engineering + Targeted Delivery of Nucleic Acid Medicines (Jan 25–28, Keystone) cover genome editing, delivery innovations & clinical translation. Short talk abstracts + $1500 scholarships close TOMORROW (Oct 1). Apply now: hubs.la/Q04xVtQN0 hubs.la/Q04xVv0z0
022
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 01/10/2026
⏰ Deadline extended to Oct 14: scholarships + short talk abstracts for Genetic Medicines to Treat Cardiovascular Disease 📍 Keystone, CO | Jan 25–28, 2027 hubs.la/Q04xTx2d0 🎥 James Ware on what to expect Joint w/ 2 meetings on genome engineering & nucleic acid delivery
012
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 25/09/2026
Read Dr. Chaim's Fellow Spotlight: keypoint.keystonesymposia.org/home/keyston...
keypoint.keystonesymposia.org
Keystone Symposia Fellow Spotlight: Dr. Alex Chaim
Discover why Keystone Symposia's Fellow Dr. Alex Chaim was inspired to study RNA damage, his recent milestones, and his dedication to science inclusivity.
032
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 25/09/2026
🔬 Meet Alex Chaim, PhD — Keystone Symposia Fellow at UCSD chasing a question the field ignored for 20 years: could damaged RNA be quietly driving Alzheimer's, Parkinson's & cancer? His lab is building the tools to find out. #RNADamage #KeystoneFellows #LatinosInSTEM
222
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 22/09/2026
We are proud to partner with @ludwigcancer.bsky.social on our Tumor and Host Metabolism meeting. Save the date and register today! March 7-10, 2027 at the Ludwig Institute for Cancer Research, Princeton Branch.
022
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Aaron Rupar @atrupar.com · 17/09/2026
here's footage of Mamdani alongside city workers filling the 200,000th NYC pothole since the start of his term This is part of his push to spotlight city workers and inform New Yorkers that all the fixes they ask for "should be directed to the real heroes, City Workers, who can be reached via 311"
215100541840
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 17/09/2026
🔬 Cancer Immunotherapy: Bridging Basic Research and Clinical Translation (Jan 24–27, Breckenridge). Upcoming deadlines: $1,500 scholarships + short talk abstracts: Sept 29. #KSCancerIO27 #scholarships
122
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 16/09/2026
Apply today: hubs.la/Q04s8Tkx0
hubs.la
Fellows Program | Keystone Symposia
The Keystone Symposia Fellows program provides training, mentorship and career development opportunities for researchers from underrepresented backgrounds!
021
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 16/09/2026
Are you a postdoc or early-career scientist? The Keystone Symposia Fellows Program may be for you. Career development. SAB meetings with leaders in your field. 1:1 mentorship. A community of Fellows committed to each other's growth. Applications close in 2 weeks on Sept. 28.
134
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 10/09/2026
Read more about our new visual ID in our latest blog: hubs.la/Q04xbtNC0
hubs.la
A Fresh Look, the Same Foundation: Introducing Keystone Symposia's Updated Visual Identity
Keystone Symposia unveils a refreshed visual identity to enhance its mission of fostering scientific discovery in the life sciences community.
021
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 10/09/2026
This fall, we are rolling out a refreshed visual identity—Designed for Discovery. Because Keystone Symposia doesn't just host 50+ conferences. We design environments that spark collaboration and transform careers. The real story: expanding scholarships, LMIC access, and more.
132
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 09/09/2026
Calling all neuroscientists 🧠 $1500 scholarship app + short talk deadlines are approaching! Sept 22: Sensory Systems + Appetite Control Sept 24: Neurodevelopmental Disorders + Neural Plasticity & Recovery 4 Neuro meetings, 1 week in January, 30 min apart in the CO Rockies.
162
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 04/09/2026
🚨Don't miss this Sept 8th deadline! Global Health Travel Awards are available for travel support to our Reimagining Diabetes conference.
062
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 01/09/2026
📌 Poster abstract deadline for Hormonal Influences on Immunity and Cancer Across the Lifespan: Sept 14. Present your work where endocrinology, immunology & oncology converge — in partnership with @endocrinesociety.bsky.social 🔬 💻 Can't attend in person? Join via livestream! #KSHormoneInflu27
132
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 01/09/2026
⌛️Only 1 more week to apply for a Global Health Travel Award to attend Reimagining Diabetes! Share this with a scientist from a low- and middle-income country who should join us and the @endocrinesociety.bsky.social in Keystone, CO this February.
131
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 28/07/2026
Read @chlazaris.bsky.social full Fellow Spotlight 👇 keypoint.keystonesymposia.org/home/keyston...
keypoint.keystonesymposia.org
Keystone Symposia Fellow Spotlight: Dr. Charalampos (Harris) A. Lazaris
Discover the inspiring journey of Dr. Charalampos A. Lazaris, a Keystone Symposia Fellow, as he advances cancer research through gene regulation and mentorship.
021
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 28/07/2026
✨ Fellow Spotlight: Dr. Charalampos Lazaris, MBA, PhD @chlazaris.bsky.social Senior Data Scientist at @novartis.bsky.social studying how cancer cells get "hooked" on gene-expression programs — and how those dependencies can be turned against the disease. 🔗 to his full story in replies #KSFellows
222
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Keystone Symposia @keystonesymposia.bsky.social · 13/08/2026
"A good mentor helps you navigate complex work environments, professional relationships, and career choices in a way that aligns with your values." — Dr. Charalampos Lazaris, KS Fellow & Oncology Data Scientist at @novartis.bsky.social Missed @chlazaris.bsky.social spotlight? Link below 👇
121
Charalampos (Harris) Lazaris, Ph.D. @chlazaris.bsky.social · 07/01/2026
Honored to join the Keystone Symposia Fellows Class of 2026! Grateful to @iannisaifantis1, @artsinyc, Matt Shirley & colleagues from @nyugrossman, @WhiteheadInst, and @broadinstitute for their support. Looking forward to what’s ahead! keypoint.keystonesymposia.org/home/welcomi... @KeystoneSymp
keypoint.keystonesymposia.org
Welcoming the Keystone Symposia Fellow's Class of 2026!
The Keystone Symposia Fellows Class of 2026 is announced, showcasing rising stars in biomedical research across the United States for this formative leadership training program.
000
Charalampos (Harris) Lazaris, Ph.D. @chlazaris.bsky.social · 15/03/2025
www.tovima.gr/print/societ...
tovima.gr
Γιατί η Ελλάδα «τρώει» το ερευνητικό δυναμικό της - ΤΟ ΒΗΜΑ
Τις δομικές αδυναμίες της έρευνας στη χώρα μας και τους λόγους που τους ανάγκασαν να παραιτηθούν από το Εθνικό Συμβούλιο Ερευνας, Τεχνολογίας και Καινοτομίας ανέλυσαν σε διαδικτυακή ημερίδα οι καθηγητ...
010
Reposted by Charalampos (Harris) Lazaris, Ph.D.
MIT Koch Institute @mitkochinstitute.bsky.social · 03/03/2025
Three cheers for three KI cancer research projects in this year’s #STATMadness. Vote now for revolutionizing chemotherapy, implantable microparticles and early lung cancer detection:    Details👇voting 👉 buff.ly/T1VqmBu  @statnews.com
MIT's mascot, Tim the Beaver, standing on a basketball court.
011
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Nature Reviews Cancer @natrevcancer.nature.com · 19/02/2025
#REVIEW 🚨 In our Feb. issue, Wang & Zhang summarize findings from genetic & epigenetic association studies performed on cohorts of survivors of childhood cancer, providing insights into the long-term adverse effects related to cancer therapy. 📖 👇 bit.ly/4eplZ...
bit.ly
Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy - Nature Reviews Cancer
In this Review, Wang and Zhang summarize the major findings of genetic and epigenetic association studies performed on cohorts of survivors of childhood cancer, which provide insights into the long-term adverse effects related to cancer therapy, and present suggestions....
074
Charalampos (Harris) Lazaris, Ph.D. @chlazaris.bsky.social · 23/12/2024
Explore emerging research with field leaders @KeystoneSymp Epigenetics in Development and Disease, this March in Banff! keysym.us/KSEpigenetics25 #KSEpigenetics25
keysym.us
Epigenetics in Development and Disease | Keystone Symposia
Join us at the Keystone Symposia on Epigenetics in Development and Disease, March 2025, in Banff, with field leaders!
010
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Ed Yong is offline @edyong209.bsky.social · 08/08/2012
Reading: @NatureNews Jay Bradner wants to thwart a cancer driver through epigenetics & he's not shy talking about it. bit.ly/MyyQNh
bit.ly
Cancer research: Open ambition - Nature
Jay Bradner believes that cancer can be defeated through ...
121
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Kyle LaHucik @kylelahucik.bsky.social · 21/11/2024
Amgen is getting a new chief scientific officer next month, the famed geneticist Howard Chang, as Jay Bradner splits his roles
endpts.com
Amgen names Stanford geneticist and biotech founder to CSO post
Howard Chang, Stanford physician-scientist and biotech co-founder, will become Amgen's new chief science officer.
021
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Mitch Guttman @mitchguttman.bsky.social · 27/11/2024
Gene regulation involves thousands of proteins that bind DNA, yet comprehensively mapping these is challenging. Our paper in Nature Genetics describes ChIP-DIP, a method for genome-wide mapping of hundreds of DNA-protein interactions in a single experiment. www.nature.com/articles/s41...
nature.com
ChIP-DIP maps binding of hundreds of proteins to DNA simultaneously and identifies diverse gene regulatory elements - Nature Genetics
ChIP-DIP (ChIP done in parallel) is a highly multiplex assay for protein–DNA binding, scalable to hundreds of proteins including modified histones, chromatin regulators and transcription factors, offe...
9382150
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Aaron Quinlan (he/him) @aaronquinlan.bsky.social · 03/12/2024
Biology of Genomes 2025 is coming up: - meeting dates: May 6 - 10, 2025 - abstract deadline: Feb 14, 2025 We hope to see you there for another great meeting with a fantastic speaker lineup! meetings.cshl.edu/meetings.asp...
meetings.cshl.edu
Biology of Genomes
Cold Spring Harbor Laboratory Meetings & Courses -- a private, non-profit institution with research programs in cancer, neuroscience, plant biology, genomics, bioinformatics.
16634
Reposted by Charalampos (Harris) Lazaris, Ph.D.
TruBlu 🌊🌊🌊 @trublu268.bsky.social · 06/12/2024
Congrats to Florida! #1 in book censorship #47 in SAT scores. Way to go! #floriduh
1175415916614
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Bluesky @bsky.app · 03/12/2024
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
456294874995
Reposted by Charalampos (Harris) Lazaris, Ph.D.
Dittie @dittie.sheshed.rocks · 02/12/2024
The EFJ will stop posting on X as of January 20, 2025. This Federation of journalists has roughly 30,000 members across 44 countries and they join several other news sources in leaving the social media platform. www.thelondoneconomic.com/news/media/e...
thelondoneconomic.com
European Federation of Journalists to stop posting content on X
The EFJ represents over 295,000 journalists in 44 countries.
22278151140